1: Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, Kullman J,

Lyons PA, Merkel PA, Savage COS, Specks U, Kain R. ANCA-associated vasculitis.
Nat Rev Dis Primers. 2020 Aug 27;6(1):71. doi: 10.1038/s41572-020-0204-y. PMID:
32855422.

2: Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Avacopan for
the Treatment of ANCA-Associated Vasculitis. N Engl J Med. 2021 Feb
18;384(7):599-609. doi: 10.1056/NEJMoa2023386. PMID: 33596356.

3: Smith RM, Jones RB, Specks U, Bond S, Nodale M, Aljayyousi R, Andrews J,

Bruchfeld A, Camilleri B, Carette S, Cheung CK, Derebail V, Doulton T, Forbess
L, Fujimoto S, Furuta S, Gewurz-Singer O, Harper L, Ito-Ihara T, Khalidi N,
Klocke R, Koening C, Komagata Y, Langford C, Lanyon P, Luqmani RA, Makino H,
McAlear CA, Monach P, Moreland LW, Mynard K, Nachman P, Pagnoux C, Pearce F, Peh
CA, Pusey C, Ranganathan D, Rhee RL, Spiera R, Sreih AG, Tesar V, Walters G,
Weisman MH, Wroe C, Merkel PA, Jayne D; RITAZAREM coinvestigators; RITAZAREM co-
investigators. Rituximab as therapy to induce remission after relapse in ANCA-
associated vasculitis. Ann Rheum Dis. 2020 Sep;79(9):1243-1249. doi:
10.1136/annrheumdis-2019-216863. Epub 2020 Jun 24. PMID: 32581088; PMCID:
PMC7456549.

4: Terrier B, Darbon R, Durel CA, Hachulla E, Karras A, Maillard H, Papo T,

Puechal X, Pugnet G, Quemeneur T, Samson M, Taille C, Guillevin L;
Collaborators. French recommendations for the management of systemic necrotizing
vasculitides (polyarteritis nodosa and ANCA-associated vasculitides). Orphanet J
Rare Dis. 2020 Dec 29;15(Suppl 2):351. doi: 10.1186/s13023-020-01621-3. Erratum
in: Orphanet J Rare Dis. 2021 Apr 6;16(1):155. PMID: 33372616; PMCID:
PMC7771069.

5: Casal Moura M, Irazabal MV, Eirin A, Zand L, Sethi S, Borah BJ, Winters JL,
Moriarty JP, Cartin-Ceba R, Berti A, Baqir M, Thompson GE, Makol A, Warrington
KJ, Thao V, Specks U, Fervenza FC. Efficacy of Rituximab and Plasma Exchange in
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney
Disease. J Am Soc Nephrol. 2020 Nov;31(11):2688-2704. doi:
10.1681/ASN.2019111197. Epub 2020 Aug 21. PMID: 32826324; PMCID: PMC7608964.

6: Salama AD. Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)-Associated

Vasculitis. Kidney Int Rep. 2019 Oct 24;5(1):7-12. doi:
10.1016/j.ekir.2019.10.005. PMID: 31922056; PMCID: PMC6943777.

7: Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, Cid
MC, Dahlsveen K, de Zoysa J, Espigol-Frigolé G, Lanyon P, Peh CA, Tesar V,
Vaglio A, Walsh M, Walsh D, Walters G, Harper L, Jayne D; European Vasculitis
Study Group (EUVAS). Mycophenolate mofetil versus cyclophosphamide for remission
induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.
Ann Rheum Dis. 2019 Mar;78(3):399-405. doi: 10.1136/annrheumdis-2018-214245.
Epub 2019 Jan 5. PMID: 30612116.

8: Walsh M, Collister D, Zeng L, Merkel PA, Pusey CD, Guyatt G, Au Peh C, Szpirt
W, Ito-Hara T, Jayne DRW; Plasma exchange and glucocorticoid dosing for patients
with ANCA-associated vasculitis BMJ Rapid Recommendations Group. The effects of
plasma exchange in patients with ANCA-associated vasculitis: an updated
systematic review and meta-analysis. BMJ. 2022 Feb 25;376:e064604. doi:
10.1136/bmj-2021-064604. PMID: 35217545.

9: Gulati K, Edwards H, Prendecki M, Cairns TD, Condon M, Galliford J, Griffith

M, Levy JB, Tam FWK, Tanna A, Pusey CD, McAdoo SP. Combination treatment with
rituximab, low-dose cyclophosphamide and plasma exchange for severe
antineutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2021
Dec;100(6):1316-1324. doi: 10.1016/j.kint.2021.08.025. Epub 2021 Sep 22. PMID:
34560140.

10: McAdoo SP, Medjeral-Thomas N, Gopaluni S, Tanna A, Mansfield N, Galliford J,

Griffith M, Levy J, Cairns TD, Jayne D, Salama AD, Pusey CD. Long-term follow-up
of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil
cytoplasm antibody-associated vasculitis. Nephrol Dial Transplant. 2019 Jan
1;34(1):63-73. doi: 10.1093/ndt/gfx378. Erratum in: Nephrol Dial Transplant.
2018 May 1;33(5):899. PMID: 29462348; PMCID: PMC6322443.

11: Trivioli G, Terrier B, Vaglio A. Eosinophilic granulomatosis with

polyangiitis: understanding the disease and its management. Rheumatology
(Oxford). 2020 May 1;59(Suppl 3):iii84-iii94. doi: 10.1093/rheumatology/kez570.
PMID: 32348510.

12: Monti S, Delvino P, Riboli M, Rebuffi C, Xoxi B, De Silvestri A, Montecucco

C. The role of trimethoprim/sulfametoxazole in reducing relapses and risk of
infections in ANCA-associated vasculitis: a meta-analysis. Rheumatology
(Oxford). 2021 Aug 2;60(8):3553-3564. doi: 10.1093/rheumatology/keab267. PMID:
33752235.

13: McClure M, Jones RB. Treatment of Relapses in ANCA-Associated Vasculitis.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):967-969. doi: 10.2215/CJN.06250519. Epub
2019 Jun 28. PMID: 31278112; PMCID: PMC6625614.

14: Bala MM, Malecka-Massalska TJ, Koperny M, Zajac JF, Jarczewski JD, Szczeklik
W. Anti-cytokine targeted therapies for ANCA-associated vasculitis. Cochrane
Database Syst Rev. 2020 Sep 29;9(9):CD008333. doi:
10.1002/14651858.CD008333.pub2. PMID: 32990324; PMCID: PMC8094990.

15: Parikh A, Devarasetti PK, Rajasekhar L. Correspondence on 'Rituximab as

therapy to induce remission after relapse in ANCA-associated vasculitis'. Ann
Rheum Dis. 2021 Feb 4:annrheumdis-2020-219312. doi:
10.1136/annrheumdis-2020-219312. Epub ahead of print. PMID: 33542103.

16: Caroti L, Cirami CL, Di Maria L, Larti A, Carta P, Dervishi E, Farsetti S,

Tsalouchos A, Novelli L, Minetti EE. Rituximab in relapsing and de novo MPO
ANCA-associated vasculitis with severe renal involvement: a case series. BMC
Nephrol. 2019 May 14;20(1):162. doi: 10.1186/s12882-019-1350-x. PMID: 31088509;
PMCID: PMC6515642.

17: Cohen Tervaert JW. Trimethoprim-sulfamethoxazole and antineutrophil

cytoplasmic antibodies-associated vasculitis. Curr Opin Rheumatol. 2018
Jul;30(4):388-394. doi: 10.1097/BOR.0000000000000508. PMID: 29621029.

18: Thietart S, Beinse G, Smets P, Karras A, Philipponnet C, Augusto JF, El

Karoui K, Mesbah R, Titeca-Beauport D, Hamidou M, Carron PL, Maurier F, Sacre K,
Cohen P, Liozon E, Blanchard-Delaunay C, Kostianovsky A, Pagnoux C, Mouthon L,
Guillevin L, Terrier B, Puéchal X; French Vasculitis Study Group. Patients of
75 years and over with ANCA-associated vasculitis have a lower relapse risk than
younger patients: A multicentre cohort study. J Intern Med. 2022
Mar;291(3):350-363. doi: 10.1111/joim.13417. Epub 2022 Jan 13. PMID: 34755398.